Avantor supplies mission-critical products, materials, equipment, and services used in biopharmaceutical production, clinical research, and advanced manufacturing. Its portfolio ranges from high-purity chemicals and lab consumables to process materials and workflow solutions, including well-known brands such as VWR and J.T.Baker. Customers include biopharma and life-sciences companies, hospitals and labs, universities and government labs, and makers of electronics and advanced materials.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,683.4 | — | 64.7 | — |
| Q3 2025 | 1,623.8 | — | -711.8 | — |
| Q4 2025 | 1,663.6 | — | 52.4 | — |
| Q1 2026 | 1,581.4 | — | 43.3 | — |
| Q2 2026 | 1,692.3 | 0.5% | 38.1 | -41.1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Brinker International, Inc. (EAT), Bio-Rad Laboratories, Inc. (BIO B), MP Materials Corp. (MP), Frontline plc (FRO), Chewy, Inc. (CHWY), UiPath, Inc. (PATH)